Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Army
Johnson and Johnson
Fish and Richardson
AstraZeneca
Moodys

Generated: April 20, 2019

DrugPatentWatch Database Preview

Scopolamine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for scopolamine and what is the scope of scopolamine freedom to operate?

Scopolamine is the generic ingredient in two branded drugs marketed by Perrigo Pharms Co and Glaxosmithkline Con, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for scopolamine. Five suppliers are listed for this compound.

Pharmacology for scopolamine
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Synonyms for scopolamine
(-)-Hyoscine
(-)-Hyoscine hydrobromide
(-)-Scopolamine
(-)-Scopolamine bromide
(+)-Hyoscine
(+)-Scopolamine
(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate
(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate
(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate
(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2R)-3-hydroxy-2-phenylpropanoate
(1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate
(1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate
(1S,3S,5R,6R,7S)-6,7-epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate
(methyl[?]yl) (2S)-3-hydroxy-2-phenyl-propanoate
[7(S)-(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)]-.alpha.-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo-[3.3.1.0^2,4]non-7-yl ester
14797-94-5
1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-, (-)-tropate (ester)
226562-00-1
28901-63-5
3-Oxa-9-azatricyclo(3.3.1.0(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester)
3-Oxa-9-azatricyclo(3.3.1.O(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester)
51-34-3
58670-87-4
6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate
6,7-Epoxytropine tropate
65319-33-7
6beta,7beta-Epoxy-1alpha,5alpha-tropan-3alpha-ol
6beta,7beta-Epoxy-3alpha-tropanyl S-(-)-tropate
97991-84-9
AB00429689
AB00429689_32
AB00429689-30
AB00429689-31
AC-968
AC1MHD40
AJ-63396
AK168126
AKOS025402477
alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
Atrochin
Atroquin
Atroscine Hydrobromide
BC216316
Beldavrin
Benzeneacetic acid, alpha-(hydroxymethyl)-, (1alpha,2beta,4beta,5alpha,7beta)-9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, (alphaS)-
Benzeneacetic acid, alpha-(hydroxymethyl)-, 9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-
Boro-Scopol
BPBio1_001049
BRD-K89923877-003-02-4
BSPBio_000953
CHEBI:16794
CHEBI:93572
CHEMBL1906925
CHEMBL3084722
CHEMBL569713
CS-6609
CS0019
DB00747
DL48G20X8X
DTXSID6023573
EC 200-090-3
EINECS 200-090-3
Epoxytropine tropate
GTPL330
HMS2090N13
HSDB 4074
HY-N0296
hydrobromicum, Scopolaminum
Hydroscine hydrobromide
Hyosceine
Hyoscine
Hyoscyine hydrobromide
Hyosol
Hysco
Isopto Hyoscine
l-Scopolamine
levo-duboisine
LS-194418
NCGC00024357-04
NCGC00024357-05
NSC61806
Oscine
Prestwick3_000877
S-(-)-Tropate
SCHEMBL16226
Scop
Scopace
Scopamin
Scopine (-)-tropate
Scopine tropate
Scopoderm
Scopolamine HCl
SEE
Skopolamin
SMP1_000270
STECJAGHUSJQJN-USLFZFAMSA-N
Transderm scop
Transderm-Scop
Tropane alkaloid
Tropic acid, 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(sup 2,4))non-7-yl ester
Tropic acid, ester with scopine
UNII-DL48G20X8X
ZINC100037020
ZINC101147375
ZINC13118910

US Patents and Regulatory Information for scopolamine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Pharms Co SCOPOLAMINE scopolamine FILM, EXTENDED RELEASE;TRANSDERMAL 078830-001 Jan 30, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline Con TRANSDERM SCOP scopolamine FILM, EXTENDED RELEASE;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for scopolamine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Con TRANSDERM SCOP scopolamine FILM, EXTENDED RELEASE;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Con TRANSDERM SCOP scopolamine FILM, EXTENDED RELEASE;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Con TRANSDERM SCOP scopolamine FILM, EXTENDED RELEASE;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Covington
Mallinckrodt
QuintilesIMS
Fish and Richardson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.